Literature DB >> 12220939

Global Initiative for Chronic Obstructive Lung Diseases (GOLD).

Suzanne Hurd1, Romain Pauwels.   

Abstract

Chronic Obstructive Pulmonary Disease (COPD) is a major cause of chronic morbidity and mortality throughout the world. In an effort to increase awareness of COPD and to develop consensus on scientific evidence for management and prevention of this disease, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) program was formed. A summary of the GOLD program is presented along with information about GOLD documents.

Entities:  

Mesh：

Year:  2002        PMID： 12220939     DOI： 10.1006/pupt.2002.0381

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN： 1094-5539            Impact factor:   3.410


  17 in total

1.  Sputum cytokine levels in patients undergoing hematopoietic SCT and comparison with healthy subjects and COPD: a pilot study.

Authors:  C Moermans; C Bonnet; E Willems; F Baron; M Nguyen; M Henket; J Sele; J-L Corhay; Y Beguin; R Louis
Journal:  Bone Marrow Transplant       Date:  2014-07-28       Impact factor: 5.483

Review 2.  Differential mortality with COVID-19 and invasive mechanical ventilation between high-income and low-and middle-income countries: a systematic review, meta-analysis, and meta-regression.

Authors:  Anwar Khedr; Hussam Al Hennawi; Ibtisam Rauf; Muhammad Khuzzaim Khan; Hisham A Mushtaq; Hana Sultana Lodhi; Juan Pablo Domecq Garces; Nitesh K Jain; Thoyaja Koritala; Syed Anjum Khan
Journal:  Infez Med       Date:  2022-03-01

3.  Assessment of COPD severity by combining pulmonary function tests and chest CT images.

Authors:  Yukitaka Nimura; Takayuki Kitasaka; Hirotoshi Honma; Hirotsugu Takabatake; Masaki Mori; Hiroshi Natori; Kensaku Mori
Journal:  Int J Comput Assist Radiol Surg       Date:  2012-12-07       Impact factor: 2.924

4.  Reversion of severe hepatopulmonary syndrome in a non cirrhotic patient after corticosteroid treatment for granulomatous hepatitis: a case report and review of the literature.

Authors:  Nikolaos Tzovaras; Aggelos Stefos; Sarah P Georgiadou; Nikolaos Gatselis; Georgia Papadamou; Eirini Rigopoulou; Maria Ioannou; Ioannis Skoularigis; Georgios N Dalekos
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

Review 5.  Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review.

Authors:  Kokuvi Atsou; Christos Chouaid; Gilles Hejblum
Journal:  BMC Med       Date:  2011-01-18       Impact factor: 8.775

6.  Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial.

Authors:  Michael A Austin; Karen E Wills; Leigh Blizzard; Eugene H Walters; Richard Wood-Baker
Journal:  BMJ       Date:  2010-10-18

7.  Evaluation of the toll-like receptor 6 Ser249Pro polymorphism in patients with asthma, atopic dermatitis and chronic obstructive pulmonary disease.

Authors:  Sabine Hoffjan; Susanne Stemmler; Qumar Parwez; Elisabeth Petrasch-Parwez; Umut Arinir; Gernot Rohde; Karin Reinitz-Rademacher; Gerhard Schultze-Werninghaus; Albrecht Bufe; Jörg T Epplen
Journal:  BMC Med Genet       Date:  2005-09-28       Impact factor: 2.103

8.  Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease.

Authors:  Gokul Krishnan; Brydon J Grant; Paola C Muti; Archana Mishra; Heather M Ochs-Balcom; Jo L Freudenheim; Maurizio Trevisan; Holger J Schünemann
Journal:  BMC Pulm Med       Date:  2006-09-05       Impact factor: 3.317

9.  Supporting smoking cessation in chronic obstructive pulmonary disease with behavioral intervention: a randomized controlled trial.

Authors:  Peian Lou; Yanan Zhu; Peipei Chen; Pan Zhang; Jiaxi Yu; Ning Zhang; Na Chen; Lei Zhang; Hongmin Wu; Jing Zhao
Journal:  BMC Fam Pract       Date:  2013-06-27       Impact factor: 2.497

10.  Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization.

Authors:  Katsunaka Mikami; Masaru Suzuki; Hiroshi Kitagawa; Masaki Kawakami; Nobuaki Hirota; Hiromichi Yamaguchi; Osamu Narumoto; Yoshiko Kichikawa; Makoto Kawai; Hiroyuki Tashimo; Hidenori Arai; Tadashi Horiuchi; Yoshio Sakamoto
Journal:  Lung       Date:  2007-08-21       Impact factor: 3.777
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.